Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/novel-drug-navenibart-hereditary-angioedema-so-far-safe-2026a10006uz?src=rss
Author :
Publish date : 2026-03-05 17:08:00
Copyright for syndicated content belongs to the linked Source.
